First Time Loading...

Sinopharm Group Co Ltd
HKEX:1099

Watchlist Manager
Sinopharm Group Co Ltd Logo
Sinopharm Group Co Ltd
HKEX:1099
Watchlist
Price: 19.8 HKD 0.92%
Updated: May 6, 2024

Sinopharm Group Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sinopharm Group Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
S
601607
600998
C
600511
000963
C
000028

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sinopharm Group Co Ltd
HKEX:1099
Cash from Operating Activities
¥11.9B
CAGR 3-Years
38%
CAGR 5-Years
33%
CAGR 10-Years
11%
S
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Cash from Operating Activities
¥5.2B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
18%
Jointown Pharmaceutical Group Co Ltd
SSE:600998
Cash from Operating Activities
¥6.3B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
China National Medicines Corp Ltd
SSE:600511
Cash from Operating Activities
¥2.7B
CAGR 3-Years
28%
CAGR 5-Years
23%
CAGR 10-Years
31%
Huadong Medicine Co Ltd
SZSE:000963
Cash from Operating Activities
¥3.3B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
N/A
C
China National Accord Medicines Corp Ltd
SZSE:000028
Cash from Operating Activities
¥2.9B
CAGR 3-Years
25%
CAGR 5-Years
17%
CAGR 10-Years
20%

See Also

What is Sinopharm Group Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
11.9B CNY

Based on the financial report for Jun 30, 2023, Sinopharm Group Co Ltd's Cash from Operating Activities amounts to 11.9B CNY.

What is Sinopharm Group Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
11%

Over the last year, the Cash from Operating Activities growth was 329%. The average annual Cash from Operating Activities growth rates for Sinopharm Group Co Ltd have been 38% over the past three years , 33% over the past five years , and 11% over the past ten years .